This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Enman Oil, Inc. (F)
Hawkins, David F.Case HBS-111057-EAccounting and ControlCompany pursues ways to reduce its debt to equity ratio by resorting to off balance sheet debt transactions.Starting at €5.74
-
Cosmeticos de Espana, S.A. (F)
Hawkins, David F.Case HBS-115020-EAccounting and ControlStarting at €5.74
-
-
Cosm ticos de Espa a, S.A. (A) (B) (C) (D) (E) (F), Teaching Note
Hawkins, David F.Teaching Note HBS-112053-EAccounting and ControlTeaching Note for 111-019, 111-020, 111-021, 111-030, and 111-119.Starting at €0.00
-
C&F Consulting, Inc.
Alison Konrad; Ken MarkCase IVEY-9B14C024-ELeadership and People ManagementIn July 2009, C&F Consulting, Inc., based in Toronto, sends a team of five brand strategists to work with a client in China on marketing and advertising for a car brand specific to the North American market. The team, consisting of four men and one woman, often meet for dinner after their day’s work, which consists of conducting a crash course in North American-style marketing for the Chinese client’s cohort of new recruits. The woman feels that ...Starting at €8.20
-
Maurice Segall
Gallo, Miguel ÁngelCase DG-962StrategyEl caso describe la carrera profesional de Maurice Segall desde su inicio en la Administración Pública de Canadá, en 1952, hasta su retiro como presidente y director general de Zayre Corporation en 1989. Zayre Corporation, bajo la dirección de Maurice Segall, pasó a ser una de las mayores empresas de Estados Unidos en la industria de cadenas de almacenes, de productos de alta rotación y bajo margen. En 1987 empezó a tener problemas en su principa...Starting at €8.20